Breaking News Instant updates and real-time market news.

RDUS

Radius Health

$18.85 /

-0.46 (-2.38%)

08:47
06/02/21
06/02
08:47
06/02/21
08:47

Radius Health reports TYMLOS added 1,650 new patients in April

Radius Health provided a business update covering continued progress for the Company. Additional business updates will be provided as progress is achieved. U.S. TYMLOS Commercial Performance: TYMLOS added ~1,650 new patients in April; 1% growth vs. trailing 4-month average ; New patients: defined as those who have been prescribed TYMLOS and received their first dose ; ~67% of new patients in April were initiated by a fracture focused bone health account; Added 45 new fracture / bone health focused prescribers during the month of April. Life Cycle: ATOM Phase 3 pivotal study on schedule for readout: 2H, 2021 ; wearABLe Phase 3 pivotal study on schedule for readout: 2H, 2021; Anticipate abaloparatide depot formulation technical development work to commence 2H, 2021. Geographic Footprint: Europe: re-submission expected for abaloparatide SC to EMA in 2H, 2021; Canada: abaloparatide SC submission - by our partner - expected in January, 2022; Japan: 'planning discussions' with PMDA, a precursor to potential abaloparatide-TD agreement with Teijin; Rest of world: multiple discussions ongoing with variety of counterparties. Intellectual Property Portfolio Advancement: Three U.S. patents are presently listed in the Orange Book for TYMLOS: U.S. Patent No. 7,803,770 which expires on April 28, 2031 and U.S. Patent Nos. 8,148,333 and 8,748,382 which each expire on October 30, 2027. A fourth U.S. patent, U.S. Patent No. 10,996,208 directed to certain methods of analyzing abaloparatide to detect and quantify presence of beta Asp10, was issued on May 4, 2021 and will be added to the Orange book listing shortly; this patent expires on April 30, 2038. A new Japanese patent covering the abaloparatide transdermal system and its use in treating osteoporosis was granted in April, 2021 and will expire October 8, 2036.

  • 09

    Jun

OTHER BREAKING NEWS FROM THE FLY

Downgrade
Generali downgraded to Hold from Buy at Societe Generale » 20:31
01/20/22
01/20
20:31
01/20/22
20:31
ARZGY

Generali

$10.72 /

-0.006 (-0.06%)

Societe Generale analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ARZGY Generali
$10.72 /

-0.006 (-0.06%)

01/19/22 Citi
Generali downgraded to Neutral from Buy at Citi
01/05/22 Deutsche Bank
Generali downgraded to Hold from Buy at Deutsche Bank
11/02/21 Citi
Generali resumed with a Buy at Citi
09/07/21 JPMorgan
Generali price target raised to EUR 22 from EUR 21 at JPMorgan
Downgrade
Munich Re downgraded to Hold from Buy at Societe Generale » 20:29
01/20/22
01/20
20:29
01/20/22
20:29
MURGY

Munich Re

$30.46 /

-0.38 (-1.23%)

Societe Generale analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MURGY Munich Re
$30.46 /

-0.38 (-1.23%)

01/06/22 Deutsche Bank
Munich Re price target raised to EUR 275 from EUR 260 at Deutsche Bank
12/10/21 Credit Suisse
Munich Re price target raised to EUR 241 from EUR 232 at Credit Suisse
11/15/21 Deutsche Bank
Munich Re price target raised to EUR 260 from EUR 245 at Deutsche Bank
09/17/21 UBS
Munich Re price target lowered to EUR 297 from EUR 299 at UBS
Upgrade
Swiss Re upgraded to Buy from Hold at Societe Generale » 20:27
01/20/22
01/20
20:27
01/20/22
20:27
SSREY

Swiss Re

$26.55 /

-0.14 (-0.52%)

Societe Generale analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SSREY Swiss Re
$26.55 /

-0.14 (-0.52%)

SSREY Swiss Re
$26.55 /

-0.14 (-0.52%)

15:22 Today Barclays
Swiss Re price target raised to CHF 98 from CHF 96 at Barclays
12/06/21 Credit Suisse
Swiss Re price target raised to CHF 98 from CHF 92 at Credit Suisse
11/01/21 Citi
Swiss Re price target raised to CHF 98 at Citi
10/06/21 Barclays
Swiss Re price target raised to CHF 92 from CHF 91 at Barclays
Earnings
Notable companies reporting before tomorrow's open » 20:25
01/20/22
01/20
20:25
01/20/22
20:25
HBAN

Huntington Bancshares

$16.66 /

-0.445 (-2.60%)

, ALLY

Ally Financial

$48.97 /

-0.04 (-0.08%)

Notable companies…

Notable companies reporting before tomorrow's open, with earnings consensus, include Huntington Bancshares (HBAN), consensus 32c... Ally Financial (ALLY), consensus $1.95.

ShowHide Related Items >><<
HBAN Huntington Bancshares
$16.66 /

-0.445 (-2.60%)

ALLY Ally Financial
$48.97 /

-0.04 (-0.08%)

HBAN Huntington Bancshares
$16.66 /

-0.445 (-2.60%)

01/12/22 UBS
Huntington Bancshares initiated with a Buy at UBS
01/10/22 Morgan Stanley
Huntington Bancshares assumed with an Equal Weight at Morgan Stanley
01/03/22 Barclays
Huntington Bancshares downgraded to Underweight from Equal Weight at Barclays
11/17/21 Wolfe Research
Huntington downgraded to Peer Perform from Outperform at Wolfe Research
ALLY Ally Financial
$48.97 /

-0.04 (-0.08%)

01/19/22 JPMorgan
Ally Financial downgraded to Neutral from Overweight at JPMorgan
12/22/21 Piper Sandler
Ally Financial price target lowered to $53 from $59 at Piper Sandler
12/02/21 Raymond James
Raymond James starts Ally at Outperform, sees benefit of diversification
12/01/21 Raymond James
Ally Financial initiated with an Outperform at Raymond James
HBAN Huntington Bancshares
$16.66 /

-0.445 (-2.60%)

ALLY Ally Financial
$48.97 /

-0.04 (-0.08%)

HBAN Huntington Bancshares
$16.66 /

-0.445 (-2.60%)

ALLY Ally Financial
$48.97 /

-0.04 (-0.08%)

Upgrade
Knorr-Bremse upgraded to Buy from Hold at Societe Generale » 20:23
01/20/22
01/20
20:23
01/20/22
20:23
KNRRY

Knorr-Bremse

$25.24 /

-0.66 (-2.55%)

Societe Generale analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KNRRY Knorr-Bremse
$25.24 /

-0.66 (-2.55%)

01/19/22 Morgan Stanley
Knorr-Bremse price target lowered to EUR 97 from EUR 99 at Morgan Stanley
11/25/21 Nord/LB
Knorr-Bremse upgraded to Buy from Hold at Nord/LB
11/15/21 Citi
Knorr-Bremse price target lowered to EUR 98 from EUR 101 at Citi
11/15/21 Morgan Stanley
Knorr-Bremse price target lowered to EUR 99 from EUR 103 at Morgan Stanley
Downgrade
dormakaba downgraded to Sell from Hold at Societe Generale » 20:20
01/20/22
01/20
20:20
01/20/22
20:20
DRRKF

dormakaba

$675.00 /

+ (+0.00%)

Societe Generale analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DRRKF dormakaba
$675.00 /

+ (+0.00%)

03/04/21 Credit Suisse
dormakaba price target raised to CHF 648 from CHF 612 at Credit Suisse
01/22/21 Oddo BHF
dormakaba upgraded to Neutral from Reduce at Oddo BHF
Upgrade
Siemens upgraded to Buy from Hold at Societe Generale » 20:16
01/20/22
01/20
20:16
01/20/22
20:16
SIEGY

Siemens

$83.08 /

+1.33 (+1.63%)

Societe Generale analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SIEGY Siemens
$83.08 /

+1.33 (+1.63%)

SIEGY Siemens
$83.08 /

+1.33 (+1.63%)

01/14/22 Barclays
Siemens price target raised to EUR 141 from EUR 130 at Barclays
01/12/22 Deutsche Bank
Siemens price target raised to EUR 185 from EUR 180 at Deutsche Bank
12/07/21 Bernstein
Siemens initiated with an Underperform at Bernstein
11/26/21 Deutsche Bank
Siemens price target raised to EUR 180 from EUR 178 at Deutsche Bank
SIEGY Siemens
$83.08 /

+1.33 (+1.63%)

SIEGY Siemens
$83.08 /

+1.33 (+1.63%)

Hot Stocks
Sensata announces new $500M buyback authorization » 20:02
01/20/22
01/20
20:02
01/20/22
20:02
ST

Sensata

$58.62 /

-1.825 (-3.02%)

Sensata "announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ST Sensata
$58.62 /

-1.825 (-3.02%)

ST Sensata
$58.62 /

-1.825 (-3.02%)

07:20 Today JPMorgan
Sensata price target raised to $67 from $64 at JPMorgan
01/14/22 Baird
Sensata downgraded to Neutral from Outperform at Baird
12/31/21 Stifel
HP Enterprise, Pure Storage among Stifel's top 2022 picks in tech supply chain
12/14/21 Evercore ISI
Evercore downgrades Sensata to In Line on 'less favorable' EV shift impact
ST Sensata
$58.62 /

-1.825 (-3.02%)

Periodicals
Peloton CEO says rumors of halting all bike/tread output false, Bloomberg says » 19:52
01/20/22
01/20
19:52
01/20/22
19:52
PTON

Peloton

$24.23 /

-7.62 (-23.92%)

The report also indicates…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PTON Peloton
$24.23 /

-7.62 (-23.92%)

PTON Peloton
$24.23 /

-7.62 (-23.92%)

16:43 Today Macquarie
Peloton demand slowdown dashes softer post-COVID landing hopes, says Macquarie
16:14 Today Baird
Peloton may discuss opportunities for cost cuts, says Baird
01/18/22 JMP Securities
Peloton price raise could bring $150M in fiscal 2023 sales, says JMP Securities
01/14/22 Loop Capital
Peloton price target lowered to $90 from $110 at Loop Capital
PTON Peloton
$24.23 /

-7.62 (-23.92%)

  • 16
    Nov
PTON Peloton
$24.23 /

-7.62 (-23.92%)

PTON Peloton
$24.23 /

-7.62 (-23.92%)

PTON Peloton
$24.23 /

-7.62 (-23.92%)

Earnings
SunPower sees Q4 adjusted EBITDA at low end of prior guidance rance » 19:48
01/20/22
01/20
19:48
01/20/22
19:48
SPWR

SunPower

$19.04 /

+0.115 (+0.61%)

Sees Q4 revenue within…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SPWR SunPower
$19.04 /

+0.115 (+0.61%)

SPWR SunPower
$19.04 /

+0.115 (+0.61%)

07:27 Today JPMorgan
SunPower price target lowered to $23 from $27 at JPMorgan
01/13/22 Morgan Stanley
Clean Tech industry view upgraded to Attractive at Morgan Stanley
01/11/22 GLJ Research
Solar bulls 'could be disappointed' about CPUC this week, says GLJ Research
01/07/22 Piper Sandler
SunPower price target lowered to $19 from $26 at Piper Sandler
SPWR SunPower
$19.04 /

+0.115 (+0.61%)

SPWR SunPower
$19.04 /

+0.115 (+0.61%)

SPWR SunPower
$19.04 /

+0.115 (+0.61%)

SPWR SunPower
$19.04 /

+0.115 (+0.61%)

Hot Stocks
Pretium announces shareholder approval of Newcrest arrangement » 19:14
01/20/22
01/20
19:14
01/20/22
19:14
PVG

Pretium Resources

$14.62 /

+0.1 (+0.69%)

, NCMGY

Newcrest Mining

$18.38 /

+0.38 (+2.11%)

Pretium Resources Inc.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PVG Pretium Resources
$14.62 /

+0.1 (+0.69%)

NCMGY Newcrest Mining
$18.38 /

+0.38 (+2.11%)

PVG Pretium Resources
$14.62 /

+0.1 (+0.69%)

11/15/21 Canaccord
Pretium Resources downgraded to Hold from Buy at Canaccord
11/10/21 Canaccord
Pretium Resources price target raised to C$18.50 from C$15.50 at Canaccord
11/10/21 CIBC
Pretium Resources price target raised to C$18.50 from C$14.50 at CIBC
11/09/21 National Bank
Pretium Resources downgraded to Tender from Outperform at National Bank
NCMGY Newcrest Mining
$18.38 /

+0.38 (+2.11%)

09/10/21 Macquarie
Newcrest Mining upgraded to Outperform from Neutral at Macquarie
04/15/21 Goldman Sachs
Newcrest Mining upgraded to Buy from Neutral at Goldman Sachs
PVG Pretium Resources
$14.62 /

+0.1 (+0.69%)

PVG Pretium Resources
$14.62 /

+0.1 (+0.69%)

NCMGY Newcrest Mining
$18.38 /

+0.38 (+2.11%)

Upgrade
Ardagh Metal Beverage upgraded to Outperform from Market Perform at BMO Capital » 19:09
01/20/22
01/20
19:09
01/20/22
19:09
AMBP

Ardagh Metal Beverage

$8.89 /

-0.125 (-1.39%)

BMO Capital analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMBP Ardagh Metal Beverage
$8.89 /

-0.125 (-1.39%)

AMBP Ardagh Metal Beverage
$8.89 /

-0.125 (-1.39%)

12/23/21 Deutsche Bank
Hertz, Nio among stocks added to Deutsche Bank's 'Fresh Money List'
12/20/21 Deutsche Bank
Ardagh Metal Beverage price target lowered to $12 from $13 at Deutsche Bank
11/23/21 RBC Capital
Ardagh Metal initiated with an Outperform at RBC Capital
11/11/21 Citi
Ardagh Metal Beverage initiated with a Buy at Citi
AMBP Ardagh Metal Beverage
$8.89 /

-0.125 (-1.39%)

AMBP Ardagh Metal Beverage
$8.89 /

-0.125 (-1.39%)

Hot Stocks
Peloton up over 2% at $24.80 afterhours following Q2 revenue update  19:06
01/20/22
01/20
19:06
01/20/22
19:06
PTON

Peloton

$24.23 /

-7.62 (-23.92%)

 
ShowHide Related Items >><<
PTON Peloton
$24.23 /

-7.62 (-23.92%)

PTON Peloton
$24.23 /

-7.62 (-23.92%)

16:43 Today Macquarie
Peloton demand slowdown dashes softer post-COVID landing hopes, says Macquarie
16:14 Today Baird
Peloton may discuss opportunities for cost cuts, says Baird
01/18/22 JMP Securities
Peloton price raise could bring $150M in fiscal 2023 sales, says JMP Securities
01/14/22 Loop Capital
Peloton price target lowered to $90 from $110 at Loop Capital
PTON Peloton
$24.23 /

-7.62 (-23.92%)

  • 16
    Nov
PTON Peloton
$24.23 /

-7.62 (-23.92%)

PTON Peloton
$24.23 /

-7.62 (-23.92%)

PTON Peloton
$24.23 /

-7.62 (-23.92%)

Hot Stocks
Vistas Media Acquisition shareholders approve combination with Anghami » 19:02
01/20/22
01/20
19:02
01/20/22
19:02
VMAC

Vistas Media Acquisition

$8.75 /

-0.05 (-0.57%)

Anghami and Vistas Media…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VMAC Vistas Media Acquisition
$8.75 /

-0.05 (-0.57%)

VMAC Vistas Media Acquisition
$8.75 /

-0.05 (-0.57%)

01/06/22 Benchmark
Vistas Media Acquisition initiated with a Buy at Benchmark
VMAC Vistas Media Acquisition
$8.75 /

-0.05 (-0.57%)

Hot Stocks
Netflix wants to establish own big video game properties » 18:47
01/20/22
01/20
18:47
01/20/22
18:47
NFLX

Netflix

$508.16 /

-6.91 (-1.34%)

Says less interesting in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NFLX Netflix
$508.16 /

-6.91 (-1.34%)

NFLX Netflix
$508.16 /

-6.91 (-1.34%)

17:14 Today Goldman Sachs
Market likely to have negative reaction to Netflix earnings, says Goldman Sachs
16:53 Today Truist
Netflix Q1 subs guidance well-below expectations, says Truist
01/19/22 Truist
Buyside sentiment on Netflix cautious ahead of earnings
01/18/22 JPMorgan
Netflix price increase to drive $1B of sales in 2022, says JPMorgan
NFLX Netflix
$508.16 /

-6.91 (-1.34%)

NFLX Netflix
$508.16 /

-6.91 (-1.34%)

NFLX Netflix
$508.16 /

-6.91 (-1.34%)

NFLX Netflix
$508.16 /

-6.91 (-1.34%)

Periodicals
Intel to unveil next step in manufacturing plans Friday, Bloomberg says » 18:33
01/20/22
01/20
18:33
01/20/22
18:33
INTC

Intel

$52.04 /

-1.56 (-2.91%)

Intel plans to announce…

Intel plans to announce Friday the next step in CEO Pat Gelsinger's plan to bolster semiconductor output in the U.S., Bloomberg's Ian King reports. The chipmaker is holding a briefing to "share details of Intel's latest plans for investment in manufacturing leadership," King says, noting that the event would coincide with one held by Ohio Governor Mike DeWine on "a historic economic development announcement for the state." Reference Link

ShowHide Related Items >><<
INTC Intel
$52.04 /

-1.56 (-2.91%)

INTC Intel
$52.04 /

-1.56 (-2.91%)

01/18/22 Citi
Citi ups Intel target, adds 'positive Catalyst Watch' on shares
01/12/22 Barclays
Intel price target raised to $50 from $45 at Barclays
01/11/22 KeyBanc
KeyBanc downgrades Intel to Sector Weight on limited catalysts
01/11/22 KeyBanc
Intel downgraded to Sector Weight from Overweight at KeyBanc
INTC Intel
$52.04 /

-1.56 (-2.91%)

INTC Intel
$52.04 /

-1.56 (-2.91%)

INTC Intel
$52.04 /

-1.56 (-2.91%)

INTC Intel
$52.04 /

-1.56 (-2.91%)

Hot Stocks
Netflix says it believes lowering prices in India will boost revenue » 18:24
01/20/22
01/20
18:24
01/20/22
18:24
NFLX

Netflix

$508.16 /

-6.91 (-1.34%)

Says believes lowering…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NFLX Netflix
$508.16 /

-6.91 (-1.34%)

NFLX Netflix
$508.16 /

-6.91 (-1.34%)

17:14 Today Goldman Sachs
Market likely to have negative reaction to Netflix earnings, says Goldman Sachs
16:53 Today Truist
Netflix Q1 subs guidance well-below expectations, says Truist
01/19/22 Truist
Buyside sentiment on Netflix cautious ahead of earnings
01/18/22 JPMorgan
Netflix price increase to drive $1B of sales in 2022, says JPMorgan
NFLX Netflix
$508.16 /

-6.91 (-1.34%)

NFLX Netflix
$508.16 /

-6.91 (-1.34%)

NFLX Netflix
$508.16 /

-6.91 (-1.34%)

NFLX Netflix
$508.16 /

-6.91 (-1.34%)

Earnings
Peloton sees Q2 revenue $1.14B, consensus $1.15B » 18:23
01/20/22
01/20
18:23
01/20/22
18:23
PTON

Peloton

$24.23 /

-7.62 (-23.92%)

Peloton provided a…

Peloton provided a business update and reported preliminary results for its second quarter Fiscal 2022 ended December 31. Total Revenue of approximately $1.14B, versus previously provided guidance of $1.1B-$1.2B. Ending Connected Fitness Subscriptions of approximately 2.77M, versus previously provided guidance of 2.8M-2.85M. Average Net Monthly Connected Fitness Churn of 0.79%. Adjusted EBITDA in a range of ($270M)-($260M), versus previously provided guidance of ($350M)-($325M). "As we discussed last quarter, we are taking significant corrective actions to improve our profitability outlook and optimize our costs across the company. This includes gross margin improvements, moving to a more variable cost structure, and identifying reductions in our operating expenses as we build a more focused Peloton moving forward. This work is still underway and we expect to have more details to share when we report earnings on February 8, 2022," said John Foley, co-founder and CEO.

ShowHide Related Items >><<
PTON Peloton
$24.23 /

-7.62 (-23.92%)

PTON Peloton
$24.23 /

-7.62 (-23.92%)

16:43 Today Macquarie
Peloton demand slowdown dashes softer post-COVID landing hopes, says Macquarie
16:14 Today Baird
Peloton may discuss opportunities for cost cuts, says Baird
01/18/22 JMP Securities
Peloton price raise could bring $150M in fiscal 2023 sales, says JMP Securities
01/14/22 Loop Capital
Peloton price target lowered to $90 from $110 at Loop Capital
PTON Peloton
$24.23 /

-7.62 (-23.92%)

  • 16
    Nov
PTON Peloton
$24.23 /

-7.62 (-23.92%)

PTON Peloton
$24.23 /

-7.62 (-23.92%)

PTON Peloton
$24.23 /

-7.62 (-23.92%)

Periodicals
Goldman Sachs raises bonus pool 40%-50% for top investment bankers, Reuters says » 18:15
01/20/22
01/20
18:15
01/20/22
18:15
GS

Goldman Sachs

$348.37 /

+1.085 (+0.31%)

Goldman Sachs raised its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GS Goldman Sachs
$348.37 /

+1.085 (+0.31%)

GS Goldman Sachs
$348.37 /

+1.085 (+0.31%)

06:18 Today Citi
Goldman Sachs price target lowered to $455 from $480 at Citi
01/19/22 Barclays
Goldman Sachs price target lowered to $505 from $556 at Barclays
01/19/22 BMO Capital
Goldman Sachs price target lowered to $448 from $455 at BMO Capital
01/19/22 Oppenheimer
Goldman Sachs price target lowered to $574 from $598 at Oppenheimer
GS Goldman Sachs
$348.37 /

+1.085 (+0.31%)

GS Goldman Sachs
$348.37 /

+1.085 (+0.31%)

GS Goldman Sachs
$348.37 /

+1.085 (+0.31%)

GS Goldman Sachs
$348.37 /

+1.085 (+0.31%)

Hot Stocks
Netflix says COVID overhang, macro strain probably affecting growth » 18:07
01/20/22
01/20
18:07
01/20/22
18:07
NFLX

Netflix

$508.16 /

-6.91 (-1.34%)

Sees no structural…

Sees no structural changes to business. Says overall COVID overhang and macroeconomic strain probably affecting net adds growth. Says big titles "still landing" with audiences. Says tough to pinpoint exactly why subscriber growth is slowing.

ShowHide Related Items >><<
NFLX Netflix
$508.16 /

-6.91 (-1.34%)

NFLX Netflix
$508.16 /

-6.91 (-1.34%)

17:14 Today Goldman Sachs
Market likely to have negative reaction to Netflix earnings, says Goldman Sachs
16:53 Today Truist
Netflix Q1 subs guidance well-below expectations, says Truist
01/19/22 Truist
Buyside sentiment on Netflix cautious ahead of earnings
01/18/22 JPMorgan
Netflix price increase to drive $1B of sales in 2022, says JPMorgan
NFLX Netflix
$508.16 /

-6.91 (-1.34%)

NFLX Netflix
$508.16 /

-6.91 (-1.34%)

NFLX Netflix
$508.16 /

-6.91 (-1.34%)

NFLX Netflix
$508.16 /

-6.91 (-1.34%)

Hot Stocks
Netflix 'quite pleased' with Q4 despite downbeat acquisition growth » 18:04
01/20/22
01/20
18:04
01/20/22
18:04
NFLX

Netflix

$508.16 /

-6.91 (-1.34%)

Says "quite…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NFLX Netflix
$508.16 /

-6.91 (-1.34%)

NFLX Netflix
$508.16 /

-6.91 (-1.34%)

17:14 Today Goldman Sachs
Market likely to have negative reaction to Netflix earnings, says Goldman Sachs
16:53 Today Truist
Netflix Q1 subs guidance well-below expectations, says Truist
01/19/22 Truist
Buyside sentiment on Netflix cautious ahead of earnings
01/18/22 JPMorgan
Netflix price increase to drive $1B of sales in 2022, says JPMorgan
NFLX Netflix
$508.16 /

-6.91 (-1.34%)

NFLX Netflix
$508.16 /

-6.91 (-1.34%)

NFLX Netflix
$508.16 /

-6.91 (-1.34%)

NFLX Netflix
$508.16 /

-6.91 (-1.34%)

Hot Stocks
Athersys appoints Daniel Camardo as CEO » 18:03
01/20/22
01/20
18:03
01/20/22
18:03
ATHX

Athersys

/

+

Athersys appointed Daniel…

Athersys appointed Daniel Camardo as CEO effective February 14. Camardo is a senior pharmaceutical and biotech executive. Camardo will also join the Board of Directors. William Lehmann, who has served most recently as interim CEO, will continue to serve as President and COO, the position he held prior to his interim appointment. Camardo currently serves as Executive VP and Head of the Rare Disease and Inflammation Business Units and President, U.S. at Horizon Therapeutics. Prior to this, he led commercial operations for Horizon. He has worked in commercial leadership roles for other biotechnology and pharmaceutical companies, including Astellas.

ShowHide Related Items >><<
ATHX Athersys
/

+

ATHX Athersys
/

+

11/19/21 BofA
Athersys downgraded to Neutral from Buy at BofA (yesterday)
02/17/21 Dawson James
Athersys management transition, standstill are positives, says Dawson James
ATHX Athersys
/

+

ATHX Athersys
/

+

ATHX Athersys
/

+

Hot Stocks
NSTS Bancorp director Dolan purchases $300K in shares » 18:01
01/20/22
01/20
18:01
01/20/22
18:01
NSTS

NSTS Bancorp

$12.50 /

-0.07 (-0.56%)

NSTS Bancorp director…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
    Periodicals
    'Call of Duty' could end yearly releases after Microsoft deal, Bloomberg says » 17:56
    01/20/22
    01/20
    17:56
    01/20/22
    17:56
    ATVI

    Activision Blizzard

    $81.79 /

    -0.39 (-0.47%)

    , MSFT

    Microsoft

    $301.47 /

    -1.81 (-0.60%)

    As a result of Activision…

    As a result of Activision Blizzard's (ATVI) proposed takeover by Microsoft (MSFT), the company's flagship "Call of Duty" franchise could move on from a yearly release schedule, Bloomberg's Jason Schreier reports. The Fly notes that "Call of Duty" has had an annual full release every single year since 2005, when "Call of Duty 2" was released. Reference Link

    ShowHide Related Items >><<
    MSFT Microsoft
    $301.47 /

    -1.81 (-0.60%)

    ATVI Activision Blizzard
    $81.79 /

    -0.39 (-0.47%)

    ATVI Activision Blizzard
    $81.79 /

    -0.39 (-0.47%)

    08:42 Today Morgan Stanley
    Sony named a 'Research Tactical Idea' at Morgan Stanley
    07:04 Today BMO Capital
    Activision Blizzard price target raised to $95 from $90 at BMO Capital
    01/19/22 BTIG
    Zynga downgraded to Neutral from Buy at BTIG
    01/19/22 RBC Capital
    RBC Capital positive on Microsoft acquisition of Activision Blizzard
    MSFT Microsoft
    $301.47 /

    -1.81 (-0.60%)

    06:16 Today Citi
    Microsoft price target lowered to $376 from $407 at Citi
    MSFT Microsoft
    $301.47 /

    -1.81 (-0.60%)

    ATVI Activision Blizzard
    $81.79 /

    -0.39 (-0.47%)

    MSFT Microsoft
    $301.47 /

    -1.81 (-0.60%)

    ATVI Activision Blizzard
    $81.79 /

    -0.39 (-0.47%)

    MSFT Microsoft
    $301.47 /

    -1.81 (-0.60%)

    ATVI Activision Blizzard
    $81.79 /

    -0.39 (-0.47%)

    MSFT Microsoft
    $301.47 /

    -1.81 (-0.60%)

    ATVI Activision Blizzard
    $81.79 /

    -0.39 (-0.47%)

    On The Fly
    Fly Intel: After-Hours Movers » 17:54
    01/20/22
    01/20
    17:54
    01/20/22
    17:54
    LLNW

    Limelight Networks

    $3.73 /

    +0.04 (+1.08%)

    , VMAC

    Vistas Media Acquisition

    $8.75 /

    -0.05 (-0.57%)

    , SNOA

    Sonoma Pharmaceuticals

    $4.31 /

    +0.03 (+0.70%)

    , NFLX

    Netflix

    $508.16 /

    -6.91 (-1.34%)

    , RBBN

    Ribbon Communications

    $5.32 /

    +0.035 (+0.66%)

    , ISRG

    Intuitive Surgical

    $292.86 /

    -0.62 (-0.21%)

    , CSX

    CSX

    $35.21 /

    -0.03 (-0.09%)

    Check out this evening's…

    ShowHide Related Items >><<
    VMAC Vistas Media Acquisition
    $8.75 /

    -0.05 (-0.57%)

    SNOA Sonoma Pharmaceuticals
    $4.31 /

    +0.03 (+0.70%)

    RBBN Ribbon Communications
    $5.32 /

    +0.035 (+0.66%)

    NFLX Netflix
    $508.16 /

    -6.91 (-1.34%)

    LLNW Limelight Networks
    $3.73 /

    +0.04 (+1.08%)

    ISRG Intuitive Surgical
    $292.86 /

    -0.62 (-0.21%)

    CSX CSX
    $35.21 /

    -0.03 (-0.09%)

    LLNW Limelight Networks
    $3.73 /

    +0.04 (+1.08%)

    01/18/22 Truist
    Limelight Networks upgraded to Buy from Hold at Truist
    01/18/22 Truist
    Limelight Networks upgraded to Buy from Hold at Truist
    12/20/21 Raymond James
    Limelight Networks upgraded to Strong Buy from Market Perform at Raymond James
    10/15/21 Craig-Hallum
    Limelight Networks upgraded to Buy from Hold at Craig-Hallum
    VMAC Vistas Media Acquisition
    $8.75 /

    -0.05 (-0.57%)

    01/06/22 Benchmark
    Vistas Media Acquisition initiated with a Buy at Benchmark
    SNOA Sonoma Pharmaceuticals
    $4.31 /

    +0.03 (+0.70%)

    NFLX Netflix
    $508.16 /

    -6.91 (-1.34%)

    17:14 Today Goldman Sachs
    Market likely to have negative reaction to Netflix earnings, says Goldman Sachs
    16:53 Today Truist
    Netflix Q1 subs guidance well-below expectations, says Truist
    01/19/22 Truist
    Buyside sentiment on Netflix cautious ahead of earnings
    01/18/22 JPMorgan
    Netflix price increase to drive $1B of sales in 2022, says JPMorgan
    RBBN Ribbon Communications
    $5.32 /

    +0.035 (+0.66%)

    01/19/22 Northland
    Ribbon Communications assumed with an Outperform at Northland
    07/29/21 B. Riley
    Ribbon Communications price target lowered to $11.50 from $13.50 at B. Riley
    04/08/21 Northland
    Ribbon could see 'healthy return' on Kandy if AVC sold, says Northland
    03/25/21 B. Riley
    Ribbon Communications pullback a buying opportunity, says B. Riley
    ISRG Intuitive Surgical
    $292.86 /

    -0.62 (-0.21%)

    01/12/22 Piper Sandler
    Intuitive Surgical 2022 procedure outlook 'touch light,' says Piper Sandler
    01/10/22 BTIG
    Intuitive Surgical upgraded to Buy from Neutral at BTIG
    12/16/21
    Fly Intel: Top five analyst upgrades
    12/16/21 Goldman Sachs
    Intuitive Surgical upgraded to Conviction Buy from Buy at Goldman Sachs
    CSX CSX
    $35.21 /

    -0.03 (-0.09%)

    07:28 Today BofA
    BofA upgrades C.H. Robinson to Buy, seeks values in Transportation
    01/05/22 Citi
    CSX price target raised to $45 from $42 at Citi
    01/04/22 Stephens
    CSX price target raised to $43 from $39 at Stephens
    12/15/21 UBS
    CSX price target raised to $42 from $39 at UBS
    RBBN Ribbon Communications
    $5.32 /

    +0.035 (+0.66%)

    NFLX Netflix
    $508.16 /

    -6.91 (-1.34%)

    LLNW Limelight Networks
    $3.73 /

    +0.04 (+1.08%)

    ISRG Intuitive Surgical
    $292.86 /

    -0.62 (-0.21%)

    CSX CSX
    $35.21 /

    -0.03 (-0.09%)

    NFLX Netflix
    $508.16 /

    -6.91 (-1.34%)

    CSX CSX
    $35.21 /

    -0.03 (-0.09%)

    SNOA Sonoma Pharmaceuticals
    $4.31 /

    +0.03 (+0.70%)

    RBBN Ribbon Communications
    $5.32 /

    +0.035 (+0.66%)

    NFLX Netflix
    $508.16 /

    -6.91 (-1.34%)

    LLNW Limelight Networks
    $3.73 /

    +0.04 (+1.08%)

    ISRG Intuitive Surgical
    $292.86 /

    -0.62 (-0.21%)

    CSX CSX
    $35.21 /

    -0.03 (-0.09%)

    NFLX Netflix
    $508.16 /

    -6.91 (-1.34%)

    LLNW Limelight Networks
    $3.73 /

    +0.04 (+1.08%)

    ISRG Intuitive Surgical
    $292.86 /

    -0.62 (-0.21%)

    CSX CSX
    $35.21 /

    -0.03 (-0.09%)

    Get Full Fly Access

    Breaking market intelligence sent straight to you
    Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
    Up-to-date information on important industry events
    Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
    News focused on the companies in your portfolio
    Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.